<--- Back to Details
First PageDocument Content
Epidermal growth factor receptor / Oncogenes / Epidermal growth factor / Phosphorylation / Signal transduction / MAPK/ERK pathway / A431 cells / Biology / Cell signaling / Cell biology
Date: 2011-09-29 00:23:32
Epidermal growth factor receptor
Oncogenes
Epidermal growth factor
Phosphorylation
Signal transduction
MAPK/ERK pathway
A431 cells
Biology
Cell signaling
Cell biology

University of Tokyo Research Internship Program 2011 Working Paper – Kuroda Lab Phosphorylation of ERK signalling pathway molecules in response to step-stimulation by Epidermal Growth Factor Sophie Andrews 1,2

Add to Reading List

Source URL: kurodalab.bi.s.u-tokyo.ac.jp

Download Document from Source Website

File Size: 403,06 KB

Share Document on Facebook

Similar Documents

AbstractProspective multicenter phase II study of the anti-EGFR (epidermal growth factor receptor) antibody panitumumab (P) in patients with platinum pre-treated, advanced head and neck squamous cell cancer (HNSCC

AbstractProspective multicenter phase II study of the anti-EGFR (epidermal growth factor receptor) antibody panitumumab (P) in patients with platinum pre-treated, advanced head and neck squamous cell cancer (HNSCC

DocID: 1rVAJ - View Document

UNIVERSITÄTSKLINIKUM Schleswig-Holstein Immuntherapie des Glioblastoms Sampson et al. - Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor

UNIVERSITÄTSKLINIKUM Schleswig-Holstein Immuntherapie des Glioblastoms Sampson et al. - Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor

DocID: 1rgeq - View Document

Abstract ErbB2 overexpression gives rise to a highly invasive, aggressive phenotype associated with an enlarged lysosomal compartment and increased activity of the lysosomal proteases, cysteine cathepsins. We have recent

Abstract ErbB2 overexpression gives rise to a highly invasive, aggressive phenotype associated with an enlarged lysosomal compartment and increased activity of the lysosomal proteases, cysteine cathepsins. We have recent

DocID: 1rdcC - View Document

Wrangling Phosphoproteomic Data to Elucidate Cancer Signaling Pathways Mark L. Grimes1*, Wan-Jui Lee2, Laurens van der Maaten2, Paul Shannon3 1 Division of Biological Sciences, University of Montana, Missoula, Montana, U

Wrangling Phosphoproteomic Data to Elucidate Cancer Signaling Pathways Mark L. Grimes1*, Wan-Jui Lee2, Laurens van der Maaten2, Paul Shannon3 1 Division of Biological Sciences, University of Montana, Missoula, Montana, U

DocID: 1qMPs - View Document

ZAI Lab and Hanmi execute a license agreement to develop novel EGFR targeted therapy for lung cancer in China Shanghai, China and Seoul, Korea, 23th November 2015 – ZAI Lab Limited and Hanmi Pharm. Co., Ltd. announced

ZAI Lab and Hanmi execute a license agreement to develop novel EGFR targeted therapy for lung cancer in China Shanghai, China and Seoul, Korea, 23th November 2015 – ZAI Lab Limited and Hanmi Pharm. Co., Ltd. announced

DocID: 1qm1i - View Document